2型糖尿病の疫学的予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
2.3 Upcoming Related Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.3 Global Trends 12
3.3.1 US 12
3.3.2 5EU 13
3.3.3 Japan 13
3.3.4 China and India 14
3.4 Forecast Methodology 14
3.4.1 Sources Used for Diagnosed Prevalence of T2D 19
3.4.2 Sources Not Used 30
3.4.3 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of T2D 31
3.5 Epidemiological Forecast for T2D (2015-2025) 42
3.5.1 Diagnosed Prevalent Cases of T2D 42
3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D 44
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D 46
3.5.4 Age-Standardized Diagnosed Prevalence of T2D 48
3.5.5 Prevalent Cases of Chronic Kidney Disease Among Diagnosed T2D Cases 49
3.5.6 Prevalent Cases of Cardiovascular Disease Among Diagnosed T2D Cases 50
3.5.7 Prevalent Cases of Overweight/Obesity Among Diagnosed T2D Cases 51
3.5.8 Prevalent Cases of Hypertension Among Diagnosed T2D Cases 52
3.5.9 Prevalent Cases of Dyslipidemia Among Diagnosed T2D Cases 53
3.6 Discussion 54
3.6.1 Epidemiological Forecast Insight 54
3.6.2 Limitations of the Analysis 55
3.6.3 Strengths of the Analysis 55
4 Appendix 57
4.1 Bibliography 57
4.2 About the Authors 64
4.2.1 Epidemiologists 64
4.2.2 Reviewers 65
4.2.3 Global Director of Therapy Analysis and Epidemiology 66
4.2.4 Global Head of Healthcare 66
4.3 About GlobalData 67
4.4 About EpiCast 67
4.5 Disclaimer 68